Jul 14, 2020
Citius Pharmaceuticals Brings on Myron S. Czuczman, M.D. as Chief Medical Officer (CMO) and Executive Vice President
Nov 21, 2019
Amgen Completes Acquisition Of Otezla® (apremilast)
Nov 13, 2019
Dragonfly Therapeutics Announces Celgene Opt-In of Third TriNKET(TM) Immunotherapy Drug Candidate
Nov 12, 2019
Skyhawk Therapeutics Announces a Second Multi-Target Collaboration Agreement with Celgene to Discover and Develop Novel Small Molecules that Modulate RNA Splicing
Oct 22, 2019
Ovizio Imaging Systems Announces iLine F and BioConnect Supply Agreements With Celgene Corporation
Aug 28, 2019
DarwinHealth Announces Compound-2-Clinic (C2C) Scientific Collaboration with Celgene to Deploy a Quantitative Systems Biology Discovery Platform to Characterize Celgene Oncology Compounds
Aug 26, 2019
Amgen To Acquire Otezla® For $13.4 Billion In Cash, Or Approximately $11.2 Billion Net Of Anticipated Future Cash Tax Benefits
Jun 14, 2019
Leoplus USA Wins Lyfebulb-Celgene 2019 "Addressing Unmet Needs in MS: An Innovation Challenge"
May 10, 2019
Lyfebulb and Celgene Announce Finalists for 2019 "Addressing Unmet Needs in MS: An Innovation Challenge"
Mar 04, 2019
Adagene Announces a Platform Evaluation of the Dynamic Precision Library with Celgene Corporation
Feb 19, 2019
Robert J. Hugin Appointed to Allergan Board of Directors
Jan 29, 2019
FACIT and Triphase Accelerator Announce New Partnership with Celgene for First-in-Class WDR5 Leukemia Therapy
Jan 28, 2019
MBC BioLabs Announces Recipients of the Golden Ticket Program
Jan 03, 2019
Celgene (CELG) Alert: Johnson Fistel Investigates Proposed Sale of Celgene Corporation; Are Celgene Shareholders Getting a Fair Deal?
Jan 02, 2019
Global Peripheral T-Cell Lymphoma (PTCL) Report 2018: Market Insights, Epidemiology and Market Forecast 2016-2027 Featuring AB Science, Celgene, CerRx & Onxeo S.A.
Jan 02, 2019
APRINOIA Therapeutics Licenses Tau PET Imaging Tracer APN-1607 to Celgene
Dec 13, 2018
Dragonfly Therapeutics Announces Celgene In-license of First Two TriNKET(TM) Immunotherapy Drug Candidates
Nov 14, 2018
Dragonfly Therapeutics Announces Expansion of its Strategic Collaboration with Celgene, Doubling the Number of Programs and Including Targets for Solid Tumor Indications
Nov 14, 2018
Lyfebulb Partners with Celgene to Inspire Patient-Driven Innovation in the Management of Multiple Sclerosis
Jun 26, 2018
Skyhawk Therapeutics Announces Strategic Collaboration with Celgene to Discover and Develop Novel mRNA Splicing Modifiers using Skyhawk's STAR* Technology Platform